HER2 signaling enhances 5'UTR-mediated translation of c-Myc mRNA

J Cell Physiol. 2004 Jul;200(1):82-8. doi: 10.1002/jcp.20012.

Abstract

The increased levels of c-Myc protein observed previously in an ovarian carcinoma cell line stably transfected to express HER2 has suggested a role for the HER2 pathway in c-Myc expression. Analysis of HER2-transfected cells stimulated with heregulin beta1 (HRG) revealed increased c-Myc protein levels but not a corresponding increase in c-Myc mRNA expression or any change in c-Myc protein half-life. Transfection of HER2-overexpressing cells with a construct containing the 5' untranslated region (5'UTR) of c-Myc mRNA originated from the P2 promoter and placed upstream of the Renilla luciferase gene, enhanced reporter expression upon stimulation with HRG. The HRG-mediated increase in reporter activity correlated with the HRG-mediated induction observed for c-Myc protein, identifying the P2-derived leader (P2L) of c-Myc mRNA as the cis-element involved in c-Myc translational induction. Both the increase in c-Myc protein levels and P2L-enhanced translational activity were inhibited by the PI3K inhibitor wortmannin. Together, these results demonstrate that HRG stimulation of HER2 overexpressing cells leads to enhanced c-Myc protein synthesis through activation of the PI3K/Akt/mTOR pathway and that the P2L of c-Myc mRNA is the element responsible for induction of c-Myc translation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5' Untranslated Regions / metabolism*
  • Androstadienes / pharmacology
  • Carcinoma / genetics
  • Carcinoma / metabolism
  • Carcinoma / pathology
  • Cell Line, Tumor
  • Clone Cells
  • Cycloheximide / pharmacology
  • Dactinomycin / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects
  • Genes, Reporter
  • Genes, erbB-2
  • Genes, myc / drug effects*
  • Humans
  • Luciferases / metabolism
  • Neuregulin-1 / metabolism*
  • Neuregulin-1 / pharmacology
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / metabolism
  • Ovarian Neoplasms / pathology
  • Phosphatidylinositol 3-Kinases / metabolism
  • Promoter Regions, Genetic
  • Protein Biosynthesis* / drug effects
  • Protein Kinases / metabolism
  • Protein Serine-Threonine Kinases*
  • Protein Synthesis Inhibitors / pharmacology
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-akt
  • Proto-Oncogene Proteins c-myc / biosynthesis*
  • Proto-Oncogene Proteins c-myc / genetics
  • RNA, Messenger / genetics*
  • RNA, Messenger / metabolism
  • Signal Transduction
  • TOR Serine-Threonine Kinases
  • Wortmannin

Substances

  • 5' Untranslated Regions
  • Androstadienes
  • Enzyme Inhibitors
  • Neuregulin-1
  • Protein Synthesis Inhibitors
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-myc
  • RNA, Messenger
  • heregulin beta1
  • Dactinomycin
  • Cycloheximide
  • Luciferases
  • Protein Kinases
  • MTOR protein, human
  • AKT1 protein, human
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • Wortmannin